|
Barbara Finn, Vice President Regulatory Affairs & Quality Assurance, manages a department that is responsible for regulatory affairs, quality assurance, medical writing, and the scientific library. Prior to joining Neurocrine as Senior Director in October 2000, Ms. Finn worked 7 years at Quintiles, Inc. in the Regulatory and Technical Services department, where she was responsible for regulatory strategy, regulatory filings, GCP compliance, and clinical project support. Prior to joining Quintiles, she spent 13 years at Ciba-Geigy Pharmaceuticals (now, Novartis), starting in medicinal chemistry, then clinical research, and ultimately joining regulatory affairs in 1988. Ms. Finn started her pharmaceutical career at Ortho Pharmaceuticals in the medicinal chemistry department after attaining her B.S. in Chemistry, with high honor, from The College of St. Elizabeth in Convent Station, New Jersey. Ms. Finn has presented at numerous DIA, RAPS, PERI and IIR conferences, has provided regulatory expert testimony, and is a former faculty member in the Masters of Regulatory Affairs program at San Diego State University. | 